Spirit Scientific Co., Ltd. (TPEX:7790)

Market Cap	911.53M -27.9%
Revenue (ttm)	273.29M +20.7%
Net Income	20.06M +297.0%
EPS	1.13 +276.7%
Shares Out	17.70M
PE Ratio	45.58
Forward PE	n/a
Dividend	0.60 (1.17%)
Ex-Dividend Date	n/a

Volume	5,620
Open	51.50
Previous Close	51.50
Day's Range	49.25 - 51.50
52-Week Range	44.90 - 87.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2026

About Spirit Scientific

Spirit Scientific Co., Ltd., a med-tech company, focuses on minimal invasive treatment for orthopedic pain relief. It offers Vessel-X, a bone filling containment system to treat patients with spinal compression fractures; Osteo-G, treatment for spinal compression fractures; cryo-crystal related products; various orthopedic medical devices; and platelet-lyophilized-treatment technology for the treatment of osteoarthritis and sports injuries. The company was founded in 2013 and is based in Taipei, Taiwan.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2013
• Employees: 81
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7790

Financial Performance

In 2025, Spirit Scientific's revenue was 273.29 million, an increase of 20.71% compared to the previous year's 226.39 million. Earnings were 20.06 million, an increase of 296.99%.